Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation

NCT: NCT07158034 · ACTIVE_NOT_RECRUITING

NCT IDNCT07158034
StatusACTIVE_NOT_RECRUITING
Start Date2025-10-03
Completion2026-11-30
SponsorUniversity of Minnesota (OTHER)
First posted
Last updated

Brief Summary

The aim of the proposed study is to investigate the use of resting-state Electroencephalogram (EEG)-Based Brain Entropy (EBDBE) and auditory brainstem responses (ABR) as an objective measure of tinnitus improvement following the use of a bimodal stimulation device in individuals with tinnitus after six weeks of bi-modal stimulation.

Frequently Asked Questions

What is Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation?

Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation is a clinical trial registered under NCT07158034. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT07158034?

The current status of NCT07158034 (Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation) is: ACTIVE_NOT_RECRUITING.

When did Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation start?

Investigating EEG as a Biomarker for Tinnitus Improvement After Bimodal Stimulation started on 2025-10-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.